An Observational Study of Patients With Dermatologic Disease
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Vitiligo, Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa (HS). Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
TARGET-DERM+ is an observational research study to conduct a comprehensive review of outcomes for patients with dermatologic disease (DD) and providers who treat these patients. The study includes patients managed for DD of any etiology in usual clinical practice in the United States and addresses important clinical questions regarding the management of DD by collecting and analyzing data from patients at academic medical centers and community medical practices and/or data from providers who treat them.
Detailed description
TARGET-DERM+ is an observational research study to conduct a comprehensive review of outcomes for patients with dermatologic disease (DD) and providers who treat these patients. The study includes patients managed for DD of any etiology in usual clinical practice in the United States and addresses important clinical questions regarding the management of DD by collecting and analyzing data from patients at academic medical centers and community medical practices and/or data from providers who treat them. TARGET-DERM+ is designed to develop a large, robust database of real-world data regarding the natural history, management, and health outcomes related to the care of DD of diverse etiologies and practice settings. The study is also designed to establish learning health networks focused on quality of care for patients with DD.
Primary outcome measures
- To assess safety and effectiveness of DD treatments and treatments for complications of any dermatologic disease [Time frame: 15 years]
- To characterize the natural history of disease in patients with dermatologic disease from various etiologies [Time frame: 15 years]
- To establish learning health networks focused on quality of care for patients [Time frame: 15 years]
Secondary outcome measures (2)
- To evaluate provider management practices in the treatment of patients with DD [Time frame: 15 years]
- To evaluate longitudinal and patient reported outcomes in DD [Time frame: 15 years]
Eligibility criteria
Inclusion criteria
- Adult or pediatric participants managed for DD invited to participate OR a provider who treats patients with these conditions. Informed consent is required for all Engaged Cohort participants.
- Adult or pediatric participants at the time of enrollment with a diagnosis of DD by ICD code or other relevant healthcare code as part of the EHR interface.
Exclusion criteria
- Participant withdrew consent; Failure to complete activities as required per the cohort clarification letter.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
United States · 3 centers
- Wake Forest University Health Science — Winston-Salem
- University of Pennsylvania — Philadelphia
- Medical University of South Carolina — Charleston
Identifiers
NCT: NCT07748169 · TARGET-DERM+